Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy J Purwin

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Cancer Research|January 15, 2021
Roles of the BAP1 Tumor Suppressor in Cell MetabolismAnna Han, Timothy J Purwin, Andrew E Aplin
Iscience|August 28, 2023
Gene signature reveals decreased SOX10-dependent transcripts in malignant cells from immune checkpoint inhibitor-resistant cutaneous melanomasTimothy J Purwin, Signe Caksa, Ahmet Sacan, et al.
Pigment Cell & Melanoma Research|July 16, 2015
RAC1 P29S regulates PD-L1 expression in melanomaHa Linh Vu, Sheera Rosenbaum, Timothy J Purwin, et al.
The Journal of Investigative Dermatology|April 9, 2025
Selective USP7 Inhibition Synergizes with MEK1/2 Inhibitor to Enhance Immune Responses and Potentiate Anti-PD-1 Therapy in NRAS-Mutant MelanomaLiya Su, Dinghao Wang, Timothy J Purwin, et al.
Journal of Virology|August 4, 2019
Murine Cytomegalovirus Infection of Melanoma Lesions Delays Tumor Growth by Recruiting and Repolarizing Monocytic Phagocytes in the TumorNicole A Wilski, Christina Del Casale, Timothy J Purwin, et al.
Cancer Research|June 3, 2022
A Genome-Wide Screen Identifies PDPK1 as a Target to Enhance the Efficacy of MEK1/2 Inhibitors in NRAS Mutant MelanomaWeijia Cai, Mai Q Nguyen, Nicole A Wilski, et al.
Pigment Cell & Melanoma Research|August 4, 2021
The AMP-dependent kinase pathway is upregulated in BAP1 mutant uveal melanomaVivian Chua, Anna Han, Nelisa Bechtel, et al.
The Journal of Investigative Dermatology|March 12, 2016
MIG6 Is MEK Regulated and Affects EGF-Induced Migration in Mutant NRAS MelanomaHa Linh Vu, Sheera Rosenbaum, Claudia Capparelli, et al.
Cancer Research|August 5, 2016
An In Vivo Reporter to Quantitatively and Temporally Analyze the Effects of CDK4/6 Inhibitor-Based Therapies in MelanomaJessica L F Teh, Timothy J Purwin, Evan J Greenawalt, et al.
Molecular Cancer Therapeutics|February 1, 2017
Co-targeting HGF/cMET Signaling with MEK Inhibitors in Metastatic Uveal MelanomaHanyin Cheng, Vivian Chua, Connie Liao, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Cancer Research|January 15, 2021
Roles of the BAP1 Tumor Suppressor in Cell MetabolismAnna Han, Timothy J Purwin, Andrew E Aplin
Iscience|August 28, 2023
Gene signature reveals decreased SOX10-dependent transcripts in malignant cells from immune checkpoint inhibitor-resistant cutaneous melanomasTimothy J Purwin, Signe Caksa, Ahmet Sacan, et al.
Pigment Cell & Melanoma Research|July 16, 2015
RAC1 P29S regulates PD-L1 expression in melanomaHa Linh Vu, Sheera Rosenbaum, Timothy J Purwin, et al.
The Journal of Investigative Dermatology|April 9, 2025
Selective USP7 Inhibition Synergizes with MEK1/2 Inhibitor to Enhance Immune Responses and Potentiate Anti-PD-1 Therapy in NRAS-Mutant MelanomaLiya Su, Dinghao Wang, Timothy J Purwin, et al.
Journal of Virology|August 4, 2019
Murine Cytomegalovirus Infection of Melanoma Lesions Delays Tumor Growth by Recruiting and Repolarizing Monocytic Phagocytes in the TumorNicole A Wilski, Christina Del Casale, Timothy J Purwin, et al.
Cancer Research|June 3, 2022
A Genome-Wide Screen Identifies PDPK1 as a Target to Enhance the Efficacy of MEK1/2 Inhibitors in NRAS Mutant MelanomaWeijia Cai, Mai Q Nguyen, Nicole A Wilski, et al.
Pigment Cell & Melanoma Research|August 4, 2021
The AMP-dependent kinase pathway is upregulated in BAP1 mutant uveal melanomaVivian Chua, Anna Han, Nelisa Bechtel, et al.
The Journal of Investigative Dermatology|March 12, 2016
MIG6 Is MEK Regulated and Affects EGF-Induced Migration in Mutant NRAS MelanomaHa Linh Vu, Sheera Rosenbaum, Claudia Capparelli, et al.
Cancer Research|August 5, 2016
An In Vivo Reporter to Quantitatively and Temporally Analyze the Effects of CDK4/6 Inhibitor-Based Therapies in MelanomaJessica L F Teh, Timothy J Purwin, Evan J Greenawalt, et al.
Molecular Cancer Therapeutics|February 1, 2017
Co-targeting HGF/cMET Signaling with MEK Inhibitors in Metastatic Uveal MelanomaHanyin Cheng, Vivian Chua, Connie Liao, et al.
Pageof 5